Bionano Genomics, Inc. (LON: 0A4K)
London
· Delayed Price · Currency is GBP · Price in USD 5.25
-0.33 (-5.83%)
At close: Jan 31, 2025
Bionano Genomics Revenue
Bionano Genomics had revenue of $6.07M USD in the quarter ending September 30, 2024, a decrease of -34.83%. This brings the company's revenue in the last twelve months to $33.33M, down -0.82% year-over-year. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.
Revenue (ttm)
$33.33M
Revenue Growth
-0.82%
P/S Ratio
n/a
Revenue / Employee
$96.90K
Employees
344
Market Cap
7.10M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 227.10B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| British American Tobacco p.l.c. | 26.18B |
| BP p.l.c. | 144.69B |